SGRY (STOCKS)
Surgery Partners, Inc. Common Stock
$13.100000
+0.010000 (+0.08%)
Prev close: $13.090000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Hospital/Nursing Management
- CEO
- J. Eric Evans
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,694.11M
- Employees
- 15,000
- P/E (TTM)
- -21.35
- P/B (TTM)
- 0.99
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
9
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.12 | $0.31 | -0.1860 | -60.78% |
|
Sep 2025 (Q3)
|
$0.13 | $0.17 | -0.0389 | -23.03% |
|
Jun 2025 (Q2)
|
$0.17 | $0.14 | +0.0331 | +24.18% |
|
Mar 2025 (Q1)
|
$0.04 | $0.05 | -0.0129 | -24.39% |
Financial Statements
| Revenues | $3.31B |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $2.92B |
| Operating Expenses | $2.92B |
| Depreciation and Amortization | $176.00M |
| Other Operating Expenses | $2.74B |
| Operating Income/Loss | $389.50M |
| Income/Loss Before Equity Method Investments | $3.29B |
| Income/Loss From Continuing Operations After Tax | $98.90M |
| Income/Loss From Continuing Operations Before Tax | $3.31B |
| Income/Loss From Equity Method Investments | $22.90M |
| Income Tax Expense/Benefit | $18.00M |
| Income Tax Expense/Benefit, Deferred | $16.70M |
| Net Income/Loss | $98.90M |
| Net Income/Loss Attributable To Noncontrolling Interest | $176.80M |
| Net Income/Loss Attributable To Parent | -$77.90M |
| Net Income/Loss Attributable To Redeemable Noncontrolling Interest | $17.20M |
| Net Income/Loss Available To Common Stockholders, Basic | -$77.90M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.61 |
| Diluted Earnings Per Share | -$0.61 |
| Basic Average Shares | 127,209,000 |
| Diluted Average Shares | 127,209,000 |
| Assets | $8.12B |
| Current Assets | $1.15B |
| Inventory | $96.60M |
| Prepaid Expenses | $41.10M |
| Other Current Assets | $1.01B |
| Noncurrent Assets | $6.97B |
| Intangible Assets | $41.00M |
| Other Non-current Assets | $6.93B |
| Liabilities | $4.99B |
| Current Liabilities | $615.50M |
| Accounts Payable | $208.70M |
| Wages | $64.90M |
| Other Current Liabilities | $341.90M |
| Noncurrent Liabilities | $4.37B |
| Long-term Debt | $3.74B |
| Other Non-current Liabilities | $637.50M |
| Redeemable Noncontrolling Interest | $395.50M |
| Equity | $3.13B |
| Equity Attributable To Noncontrolling Interest | $1.42B |
| Equity Attributable To Parent | $1.71B |
| Temporary Equity | $395.50M |
| Liabilities And Equity | $8.12B |
| Net Cash Flow From Operating Activities | $274.30M |
| Net Cash Flow From Operating Activities, Continuing | $274.30M |
| Net Cash Flow From Investing Activities | -$246.60M |
| Net Cash Flow From Investing Activities, Continuing | -$246.60M |
| Net Cash Flow From Financing Activities | -$57.30M |
| Net Cash Flow From Financing Activities, Continuing | -$57.30M |
| Net Cash Flow | -$29.60M |
| Net Cash Flow, Continuing | -$29.60M |
| Comprehensive Income/Loss | $80.30M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $176.80M |
| Comprehensive Income/Loss Attributable To Parent | -$96.50M |
| Other Comprehensive Income/Loss | -$18.60M |